Announcement of the resolution of the first extraordinary general meeting of shareholders in 2023

release time:

2023-08-04 16:08

Stock code: 832316 Securities abbreviation: Tim Zheng Biotech Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2023

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume responsibility for the authenticity, accuracy and completeness of the contentNo joint and several liability.

 

1. Convening and attendance at meetings
(1) The convening of the meeting
1. The meeting will be held on May 2023, 2
2. Meeting location: conference room on the third floor of the company
3. Meeting mode: √ on-site voting□ online voting□ other ways of voting
4. Meeting Convener: Board of Directors
5. Meeting host: Chairman Cai Tiyuan
6.Convening SituationLegal Compliance Statement:
The convening and convening of this general meeting of shareholders complies with the provisions of the Company Law, the Securities Law and other relevant laws, administrative regulations, departmental rules, normative documents and the Articles of Association.
(2) Attendance at the meeting
A total of 8 shareholders attended and authorized to attend this general meeting, with a total of 60,138,675 voting shares, accounting for 53.22% of the total number of voting shares of the company.
The company's directors, supervisors and senior management attended the shareholders' general meeting as observers
1. The company has 5 directors and 5 non-voting members;
2. The company has 3 supervisors and 3 non-voting members;
3. The secretary of the company's board of directors attends the meeting as an observer;
4. Senior management of the company attended the meeting as observers.

 

2. Deliberation of motions
(1) Deliberate and adopt the bill on "Related Party Transactions"
1. Content of the motion:
Due to the company's production and operation needs, the company intends to purchase bone grains and other raw materials from Dongfeng Shenghe Bone Products Co., Ltd., and the purchase amount is expected to not exceed RMB 2023 million from January to March 1. Hunchun Yijia Pharmacy intends to purchase drugs from the company, and the purchase amount is expected to not exceed RMB 3,900 from January to February 2023.
The company intends to purchase organic mud fermentation treatment services from gelatin production from Jilin Xintiandi Fertilizer Industry Co., Ltd., and the transaction amount is expected to not exceed RMB 2023 million in 200.
2. Voting results of motions:
60,138,675 Approved Shares of Common Stock, representing 100% of the total number of voting shares at this General Meeting; 0 opposing shares, representing 0% of the total number of voting shares at this general meeting; 0 abstained shares, representing 0% of the total number of voting shares at the General Meeting.
3. Recusal from voting
Not.
3. Catalog of documents for reference
"Resolution of the First Extraordinary General Meeting of Shareholders of Jilin Tianzheng Biotechnology Co., Ltd. in 2023"

 

Jilin Tianzheng Biotechnology Co., Ltd
board of directors
June 2023, 2